AAM Sees Boon From Biden Order And CMS Biosimilar Action

US Generics And Biosimilars Industry Association Welcomes Latest Developments

 
• By David Wallace
Joe Biden Black Background
Biden’s executive order is aimed at lowering prescription drug costs • Source: Shutterstock

More from Policy & Regulation

More from Generics Bulletin